Insider Transactions Reported by 17 Insiders of Annexon, Inc.

Symbol
ANNX on Nasdaq
Location
Brisbane, CA

Insiders trading volume in the past year

Annexon, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Muneer A. Satter Director $41.6M +$8.66M +26.2% 20 Nov 2025
Bain Capital Life Sciences Investors, LLC 10%+ Owner $24.4M 25 May 2023
Douglas Love PRESIDENT AND CEO, Director $1.04M -$14.8K -1.41% 27 Feb 2025
Michael Overdorf Evp & Chief Business Officer $341K -$26K -7.09% 14 Jul 2025
Jennifer Lew Evp & Chief Financial Officer $314K -$28.4K -8.3% 14 Jul 2025
Ted Yednock Evp & Chief Innovation Officer $271K -$32.5K -10.7% 14 Jul 2025
DEAN RICHARD ARTIS Evp & Chief Scientific Officer $249K -$16.4K -6.17% 27 Feb 2025
William H. Carson Director $225K +$72.7K +47.8% 01 Dec 2025
Jung Choi Director $138K +$138K 01 Dec 2025
Jamie Dananberg Chief Medical Officer $99.1K -$16.3K -14.2% 27 Feb 2025
Larry Mattheakis EVP & Chief Scientific Officer $77.7K 11 Jul 2022
Sanjay Chandru Keswani EVP & Chief Medical Officer $56.5K 11 Feb 2022
Bettina M. Cockroft Director 05 Jun 2025
William Waddill Director 05 Jun 2025
Ricky Sun Director 02 Jun 2021
THOMAS G. WIGGANS Director 05 Jun 2025
WILLIAM JONES Director 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for Annexon, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.